Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
Public ClinicalTrials.gov record NCT00031187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Taxotere in Patients With Hormone Refractory Prostate Carcinoma
Study identification
- NCT ID
- NCT00031187
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Seagen Inc.
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- SGN-15 (cBR96-doxorubicin immunoconjugate) Drug
- Taxotere (docetaxel) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2000
- Primary completion
- Not listed
- Completion
- Jun 30, 2003
- Last update posted
- Oct 23, 2011
2000 – 2003
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Highlands Oncology Group | Springdale | Arkansas | 72764 | — |
| West Los Angeles - VA Healthcare Center | Los Angeles | California | 90073 | — |
| VA Medical Center of Palo Alto | Palo Alto | California | 94304 | — |
| Sharp HealthCare, Sidney Kimmel Cancer Center | San Diego | California | 92121 | — |
| Bendheim Cancer Center | Greenwich | Connecticut | 06830 | — |
| Broward Oncology Associates | Fort Lauderdale | Florida | 33308 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Innovative Medical Research of South Florida | Miami Shores | Florida | 33138 | — |
| St. Joseph Mercy Oakland Hospital | Pontiac | Michigan | 33308 | — |
| Arlington Fairfax Hematology-Oncology, P.C. | Arlington | Virginia | 22205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00031187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00031187 live on ClinicalTrials.gov.